Related Experiment Video
Updated: Oct 31, 2025
Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Cell Death and Exosomes Regulation After Myocardial Infarction and Ischemia-Reperfusion
Xun Wu1, Chukwuemeka Daniel Iroegbu1, Jun Peng2
1Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.
Insights
Cardiovascular disease causes significant myocardial damage. This review explores how cell-derived exosomes can reduce cell death after myocardial infarction (MI) by regulating cell death pathways for better treatment.
Area of Science:
- Cardiology
- Regenerative Medicine
- Cell Biology
Background:
- Cardiovascular disease (CVD) is a leading global cause of death, with myocardial infarction (MI) causing significant heart damage.
- Cell death pathways are critical in determining infarct size and patient prognosis following MI or ischemic-reperfusion (I/R) injury.
- While cell therapy for MI shows promise, exosomes are gaining attention due to their potential to overcome immunogenicity issues associated with cell-based treatments.
Purpose of the Study:
- To review the role of cell-derived exosomes in mitigating myocardial cell death after MI.
- To explore how exosomes regulate cell death pathways to promote myocardial repair.
- To provide a reference for clinical applications of exosome-based therapies for MI.
Main Methods:
- Literature review focusing on cell-derived exosomes and their impact on myocardial cell death.
- Analysis of studies investigating exosome-mediated regulation of cell death pathways post-MI.
- Synthesis of current evidence on exosome therapy for myocardial repair.
Main Results:
- Exosomes, as extracellular vesicles, contain bioactive molecules that can influence cell death processes.
- Various stem cell-derived exosomes have demonstrated potential in reducing cell death and promoting myocardial repair after MI.
- Exosomes offer a promising cell-free therapeutic strategy for managing MI by modulating cell death.
Conclusions:
- Cell-derived exosomes represent a novel therapeutic avenue for reducing cell death in myocardial infarction.
- Understanding exosome-mediated regulation of cell death pathways is crucial for advancing myocardial repair strategies.
- Exosome-based interventions hold potential for future clinical applications in treating cardiovascular disease.
Abstract:
Cardiovascular disease (CVD) is the leading cause of death in the global population, accounting for about one-third of all deaths each year. Notably, with CVDs, myocardial damages result from myocardial infarction (MI) or cardiac arrhythmias caused by interrupted blood flow. Significantly, in the process of MI or myocardial ischemic-reperfusion (I/R) injury, both regulated and non-regulated cell death methods are involved. The critical factor for patients' prognosis is the infarct area's size, which determines the myocardial cells' survival. Cell therapy for MI has been a research hotspot in recent years; however, exosomes secreted by cells have attracted much attention following shortcomings concerning immunogens. Exosomes are extracellular vesicles containing several biologically active substances such as lipids, nucleic acids, and proteins. New evidence suggests that exosomes play a crucial role in regulating cell death after MI as exosomes of various stem cells can participate in the cell damage process after MI. Hence, in the review herein, we focused on introducing various cell-derived exosomes to reduce cell death after MI by regulating the cell death pathway to understand myocardial repair mechanisms better and provide a reference for clinical treatment.
Related Concept Videos
01:31Regulation of the Unfolded Protein Response
01:17The Extrinsic Apoptotic Pathway